FIELD: veterinary medicine.
SUBSTANCE: invention relates to a method for the protection of pigs from the infection of porcine circovirus of type 2. The method includes the administration to a pig of a vaccine containing ORF2-encoded protein of porcine circovirus 2 (hereinafter – PCV2) and a pharmaceutically acceptable carrier. The vaccine includes 5-20 mkg per dose of ORF2-encoded protein. Protein is protein of porcine circovirus of genotype 2b.
EFFECT: vaccine provides the protection from PCV2 of genotype 2d at a level corresponding to the protection given when a pig is vaccinated with ORF2-encoded protein of PCV2d; method provides for the improvement of the protection of pigs from the infection of PCV2.
6 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT EXPRESSION OF PROTEIN ORF2 PCV2b IN INSECT CELLS | 2018 |
|
RU2779423C2 |
| RECOMBINANT VIRUS-LIKE CIRCOVIRUS CAPSID PARTICLE (VLP): COMPOSITIONS, METHODS AND USES | 2020 |
|
RU2817679C2 |
| VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
| METHODS AND COMPOSITIONS FOR IMMUNISATION OF PIGS AGAINST PORCINE CIRCOVIRUS | 2008 |
|
RU2493254C9 |
| PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
| INTRADERMAL VACCINE AGAINST PCV2 AND PRRS VIRUS INFECTION | 2017 |
|
RU2746127C2 |
| PCV2B DIVERGENT VACCINE COMPOSITION AND METHODS OF USE | 2014 |
|
RU2662685C2 |
| METHOD FOR PREPARING A READY-TO-USE COMBINED PCV2 / MYCOPLASMA HYOPNEUMONIAE VACCINE | 2015 |
|
RU2731845C2 |
| COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
| VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
